--- title: "12 Health Care Stocks Moving In Wednesday's After-Market Session" description: "In Wednesday's after-market session, CASI Pharmaceuticals saw a significant gain of 54.2%, reaching $0.32, while Curanex Pharmaceuticals and Jyong Biotech rose by 8.62% and 7.43%, respectively. Arcuti" type: "news" locale: "en" url: "https://longbridge.com/en/news/276938119.md" published_at: "2026-02-25T21:07:13.000Z" --- # 12 Health Care Stocks Moving In Wednesday's After-Market Session > In Wednesday's after-market session, CASI Pharmaceuticals saw a significant gain of 54.2%, reaching $0.32, while Curanex Pharmaceuticals and Jyong Biotech rose by 8.62% and 7.43%, respectively. Arcutis Biotherapeutics also increased by 7.11%. On the downside, PROCEPT BioRobotics fell by 10.4% to $24.94, with Jaguar Health and ProMIS Neurosciences declining by 4.6% and 4.34%. Agilon Health and Cardio Diagnostics Hldgs also experienced losses of 3.98% and 3.96%. The Q4 earnings reports were released today for several companies. ### Gainers - **CASI Pharmaceuticals** (NASDAQ:CASI) shares rose 54.2% to $0.32 during Wednesday's after-market session. The company's market cap stands at $12.3 million. - **Curanex Pharmaceuticals** (NASDAQ:CURX) stock moved upwards by 8.62% to $0.34. The market value of their outstanding shares is at $8.5 million. - **Jyong Biotech** (NASDAQ:MENS) stock increased by 7.43% to $2.6. The company's market cap stands at $209.8 million. - **Arcutis Biotherapeutics** (NASDAQ:ARQT) shares moved upwards by 7.11% to $28.93. The market value of their outstanding shares is at $3.3 billion. As per the news, the Q4 earnings report came out today. - **Ernexa Therapeutics** (NASDAQ:ERNA) shares rose 5.29% to $0.31. The company's market cap stands at $8.1 million. - **Quince Therapeutics** (NASDAQ:QNCX) shares increased by 2.87% to $0.14. The market value of their outstanding shares is at $7.7 million. ### Losers - **PROCEPT BioRobotics** (NASDAQ:PRCT) stock decreased by 10.4% to $24.94 during Wednesday's after-market session. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today. - **Jaguar Health** (NASDAQ:JAGX) shares decreased by 4.6% to $0.83. The market value of their outstanding shares is at $3.0 million. - **ProMIS Neurosciences** (NASDAQ:PMN) stock fell 4.34% to $19.0. The market value of their outstanding shares is at $38.6 million. - **Lantern Pharma** (NASDAQ:LTRN) stock decreased by 4.19% to $2.75. The company's market cap stands at $28.7 million. - **Agilon Health** (NYSE:AGL) shares declined by 3.98% to $0.48. The market value of their outstanding shares is at $163.2 million. The company's, Q4 earnings came out today. - **Cardio Diagnostics Hldgs** (NASDAQ:CDIO) shares decreased by 3.96% to $5.1. The market value of their outstanding shares is at $6.0 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [VHT.US - VG Health](https://longbridge.com/en/quote/VHT.US.md) - [BBH.US - VanEck Biotech ETF](https://longbridge.com/en/quote/BBH.US.md) - [IBBQ.US - Invesco Nasdaq Biotechnology ETF](https://longbridge.com/en/quote/IBBQ.US.md) - [SBIO.US - ALPS Medical Breakthrough](https://longbridge.com/en/quote/SBIO.US.md) - [IDNA.US - iShares Genomics Immunology and Healthcare ETF](https://longbridge.com/en/quote/IDNA.US.md) - [IHI.US - iShares US Medical Devices](https://longbridge.com/en/quote/IHI.US.md) - [CDIO.US - Cardio Diagnostics](https://longbridge.com/en/quote/CDIO.US.md) - [XLV.US - Health Care Select Sector SPDR](https://longbridge.com/en/quote/XLV.US.md) - [XHE.US - SPDR S&P Health Equip](https://longbridge.com/en/quote/XHE.US.md) - [IHF.US - iShares US Healthcare Providers](https://longbridge.com/en/quote/IHF.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | PROCEPT BioRobotics｜8-K：2025 财年 Q4 营收 76.38 百万美元不及预期 | | [Link](https://longbridge.com/en/news/276937893.md) | | PROCEPT BioRobotics 未能达到第四季度收入和调整后 EBITDA 的预期 | Procept Biorobotics 报告称，第四季度收入同比增长 12%，但未能达到分析师预期，实际收入为 7638 万美元，而共识为 9414 万美元。该公司还报告了 1900 万美元的调整后 EBITDA 亏损。尽管业绩不及预期，P | [Link](https://longbridge.com/en/news/276939780.md) | | Arcutis Biotherapeutics｜8-K：2025 财年 Q4 营收 1.3 亿美元超过预期 | | [Link](https://longbridge.com/en/news/276937265.md) | | Arcutis Biotherapeutics｜10-K：2025 财年营收 3.76 亿美元超过预期 | | [Link](https://longbridge.com/en/news/276938833.md) | | Palisade Bio 将在 TD Cowen 第 46 届年度医疗保健会议上发表演讲 | Palisade Bio Inc. 将于 2026 年 3 月 2 日在波士顿举行的 TD Cowen 第 46 届年度医疗保健会议上进行演讲，并将在 2026 年 3 月 8 日至 11 日在迈阿密举行的 Leerink Partners | [Link](https://longbridge.com/en/news/277479014.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.